Search for other papers by Fahim U. Hassan in
Google Scholar
PubMed
Search for other papers by Hosahalli K. Mohan in
Google Scholar
PubMed
diagnosis of papillary thyroid cancer and 9 of follicular thyroid cancer; 29 patients had 1 radioiodine therapy and 38 had subsequent radioiodine therapies for remnant, recurrence or metastatic disease. The prescribed activity of 131 I which patients
Search for other papers by Furio Pacini in
Google Scholar
PubMed
Search for other papers by Dagmar Fuhrer in
Google Scholar
PubMed
Search for other papers by Rossella Elisei in
Google Scholar
PubMed
Search for other papers by Daria Handkiewicz-Junak in
Google Scholar
PubMed
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
Search for other papers by Markus Luster in
Google Scholar
PubMed
Search for other papers by Martin Schlumberger in
Google Scholar
PubMed
Search for other papers by Johannes W Smit in
Google Scholar
PubMed
radioiodine imaging and therapy in differentiated thyroid cancer . Endocrinology and Metabolism Clinics of North America 2017 46 783 – 793 . ( https://doi.org/10.1016/j.ecl.2017.04.007 ) 10 Pacini F Schlumberger M Harmer C Berg GG Cohen O Duntas
Search for other papers by E.N. Klein Hesselink in
Google Scholar
PubMed
Search for other papers by T.P. Links in
Google Scholar
PubMed
, standardized treatment has consisted of a total thyroidectomy accompanied by a central or lateral neck lymph node dissection if indicated, followed by radioiodine ( 131 I) ablation, and thyroid hormone suppression therapy (THST) during follow-up. Although
Search for other papers by Shakeel Kautbally in
Google Scholar
PubMed
Search for other papers by Orsalia Alexopoulou in
Google Scholar
PubMed
Search for other papers by Chantal Daumerie in
Google Scholar
PubMed
Search for other papers by François Jamar in
Google Scholar
PubMed
Search for other papers by Michel Mourad in
Google Scholar
PubMed
Search for other papers by Dominique Maiter in
Google Scholar
PubMed
the development of a goiter and hyperthyroidism. Treatment should aim at inducing a rapid and permanent remission of hyperthyroidism and a disappearance of TSI with minimal morbidity. Thyroid surgery and radioiodine (RAI) therapy are both used as
Search for other papers by Steen J. Bonnema in
Google Scholar
PubMed
Search for other papers by Elisabeth S. Stovgaard in
Google Scholar
PubMed
Search for other papers by Søren Fast in
Google Scholar
PubMed
Search for other papers by Kasper Broedbaek in
Google Scholar
PubMed
Search for other papers by Jon T. Andersen in
Google Scholar
PubMed
Search for other papers by Allan Weimann in
Google Scholar
PubMed
Search for other papers by Peter Grupe in
Google Scholar
PubMed
Search for other papers by Laszlo Hegedüs in
Google Scholar
PubMed
Department of Clinical Pharmacology, Bispebjerg Hospital
Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Henrik E. Poulsen in
Google Scholar
PubMed
University Hospital, and Laszlo Hegedüs is supported by an unrestricted grant from the Novo Nordisk Foundation. Disclosure Statement All authors declare no conflicts of interest. References 1 Bonnema SJ, Hegedüs L: Radioiodine therapy in
Centre for Exercise, Nutrition and Health Sciences, School for Policy Studies, University of Bristol, Bristol, United Kingdom
Search for other papers by Clare Yvonne England in
Google Scholar
PubMed
Search for other papers by Laura Moss in
Google Scholar
PubMed
Search for other papers by Matthew Beasley in
Google Scholar
PubMed
Search for other papers by Ingrid Haupt-Schott in
Google Scholar
PubMed
Search for other papers by Georgia Herbert in
Google Scholar
PubMed
Search for other papers by Charlotte Atkinson in
Google Scholar
PubMed
://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/thyroid-cancer/incidence 3 Luster M , Clarke SE , Dietlein M , Lassmann M , Lind P , Oyen WJ , et al. ; European Association of Nuclear Medicine (EANM) . Guidelines for radioiodine therapy of differentiated thyroid cancer . Eur J Nucl Med Mol Imaging
Search for other papers by Pedro Weslley Rosario in
Google Scholar
PubMed
Search for other papers by Gabriela Franco Mourão in
Google Scholar
PubMed
Search for other papers by Maria Regina Calsolari in
Google Scholar
PubMed
Introduction Ultrasonography (US) is a widely available, noninvasive, and sensitive technique for the detection of locoregional disease in patients operated on for papillary thyroid carcinoma (PTC). After ablation or adjuvant therapy with
Search for other papers by Yaser Jbara in
Google Scholar
PubMed
Search for other papers by Dean Bricker in
Google Scholar
PubMed
therapy and hypothyroid states may increase the risk of myopathy [ 11 ]. We describe a case of significant myositis and rhabdomyolysis likely attributed to thyroid hormone withdrawal in anticipation of adjuvant radioiodine ( 131 I) therapy in a patient
Search for other papers by Shi Hui Junice Wong in
Google Scholar
PubMed
Established Facts Radioiodine (RAI) therapy for Graves’ disease is generally well tolerated. RAI therapy can rarely cause radiation-induced thyroiditis, but this is self-limiting and localized to the thyroid gland. Novel
Search for other papers by Rosa M. García-Moreno in
Google Scholar
PubMed
Search for other papers by Cristina Escabias in
Google Scholar
PubMed
Search for other papers by Cristina Utrilla in
Google Scholar
PubMed
Search for other papers by Elena Ruiz-Bravo in
Google Scholar
PubMed
Search for other papers by Margarita Sánchez in
Google Scholar
PubMed
Search for other papers by Beatriz Lecumberri in
Google Scholar
PubMed
Established Facts Orbital radioiodine uptake is highly uncommon, and some conditions associated with this finding are metastases as well as false-positive results due to contamination, inflammation, etc. Cystic structures located in
